Central nervous system (CNS) penetration of homoharringtonine (HHT)

Niramol Savaraj, Lynn G Feun, Katherine Lu, Maam Leavens, Richard Moser, William S. Fields, Ti Li Loo

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Generally tritiated homoharringtonine ([3H]HHT, 150 μCi, 430 μg) was administered intravenously to seven patients at varying times before surgical resection of malignant brain tumor. Plasma, urine, cerebrospinal fluid (CSF), and tumor specimens were obtained during surgery, and the concentrations of HHT, its major metabolite, and [3H]HHT equivalent were determined chromatographically and radiochemically. For [3H]HHT equivalent, the concentration in tumor ranged from 0.6 to 4.3 ng/g and the ratio of tumor to plasma concentration from 0.5 to 1.8. In one patient who had CSF available for drug determination, the CSF to plasma ratio of total [3H]HHT was 0.3 at 45 minutes after drug administration and less than 0.2 ng/ml was unchanged HHT. For unchanged HHT, drug concentration in tumor ranged from undetectable (4 patients) to 1.8 ng/g. A major metabolite of HHT was detectable in the tumor specimens of all the patients. These results indicate that homoharringtonine can penetrate into brain tumors; in 3 patients with brain tumors, the ratios of HHT concentration in the tumor to that in the concurrent plasma were greater than one.

Original languageEnglish
Pages (from-to)77-81
Number of pages5
JournalJournal of Neuro-Oncology
Volume5
Issue number1
DOIs
StatePublished - Mar 1 1987

Fingerprint

Central Nervous System
Brain Neoplasms
Cerebrospinal Fluid
Neoplasms
homoharringtonine
Pharmaceutical Preparations
Urine

Keywords

  • central nervous system
  • homoharringtonine
  • penetration

ASJC Scopus subject areas

  • Neuroscience(all)
  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Central nervous system (CNS) penetration of homoharringtonine (HHT). / Savaraj, Niramol; Feun, Lynn G; Lu, Katherine; Leavens, Maam; Moser, Richard; Fields, William S.; Loo, Ti Li.

In: Journal of Neuro-Oncology, Vol. 5, No. 1, 01.03.1987, p. 77-81.

Research output: Contribution to journalArticle

Savaraj, Niramol ; Feun, Lynn G ; Lu, Katherine ; Leavens, Maam ; Moser, Richard ; Fields, William S. ; Loo, Ti Li. / Central nervous system (CNS) penetration of homoharringtonine (HHT). In: Journal of Neuro-Oncology. 1987 ; Vol. 5, No. 1. pp. 77-81.
@article{63f7e4629ae94b6d8f0dcbeba4b9c678,
title = "Central nervous system (CNS) penetration of homoharringtonine (HHT)",
abstract = "Generally tritiated homoharringtonine ([3H]HHT, 150 μCi, 430 μg) was administered intravenously to seven patients at varying times before surgical resection of malignant brain tumor. Plasma, urine, cerebrospinal fluid (CSF), and tumor specimens were obtained during surgery, and the concentrations of HHT, its major metabolite, and [3H]HHT equivalent were determined chromatographically and radiochemically. For [3H]HHT equivalent, the concentration in tumor ranged from 0.6 to 4.3 ng/g and the ratio of tumor to plasma concentration from 0.5 to 1.8. In one patient who had CSF available for drug determination, the CSF to plasma ratio of total [3H]HHT was 0.3 at 45 minutes after drug administration and less than 0.2 ng/ml was unchanged HHT. For unchanged HHT, drug concentration in tumor ranged from undetectable (4 patients) to 1.8 ng/g. A major metabolite of HHT was detectable in the tumor specimens of all the patients. These results indicate that homoharringtonine can penetrate into brain tumors; in 3 patients with brain tumors, the ratios of HHT concentration in the tumor to that in the concurrent plasma were greater than one.",
keywords = "central nervous system, homoharringtonine, penetration",
author = "Niramol Savaraj and Feun, {Lynn G} and Katherine Lu and Maam Leavens and Richard Moser and Fields, {William S.} and Loo, {Ti Li}",
year = "1987",
month = "3",
day = "1",
doi = "10.1007/BF00162769",
language = "English",
volume = "5",
pages = "77--81",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Central nervous system (CNS) penetration of homoharringtonine (HHT)

AU - Savaraj, Niramol

AU - Feun, Lynn G

AU - Lu, Katherine

AU - Leavens, Maam

AU - Moser, Richard

AU - Fields, William S.

AU - Loo, Ti Li

PY - 1987/3/1

Y1 - 1987/3/1

N2 - Generally tritiated homoharringtonine ([3H]HHT, 150 μCi, 430 μg) was administered intravenously to seven patients at varying times before surgical resection of malignant brain tumor. Plasma, urine, cerebrospinal fluid (CSF), and tumor specimens were obtained during surgery, and the concentrations of HHT, its major metabolite, and [3H]HHT equivalent were determined chromatographically and radiochemically. For [3H]HHT equivalent, the concentration in tumor ranged from 0.6 to 4.3 ng/g and the ratio of tumor to plasma concentration from 0.5 to 1.8. In one patient who had CSF available for drug determination, the CSF to plasma ratio of total [3H]HHT was 0.3 at 45 minutes after drug administration and less than 0.2 ng/ml was unchanged HHT. For unchanged HHT, drug concentration in tumor ranged from undetectable (4 patients) to 1.8 ng/g. A major metabolite of HHT was detectable in the tumor specimens of all the patients. These results indicate that homoharringtonine can penetrate into brain tumors; in 3 patients with brain tumors, the ratios of HHT concentration in the tumor to that in the concurrent plasma were greater than one.

AB - Generally tritiated homoharringtonine ([3H]HHT, 150 μCi, 430 μg) was administered intravenously to seven patients at varying times before surgical resection of malignant brain tumor. Plasma, urine, cerebrospinal fluid (CSF), and tumor specimens were obtained during surgery, and the concentrations of HHT, its major metabolite, and [3H]HHT equivalent were determined chromatographically and radiochemically. For [3H]HHT equivalent, the concentration in tumor ranged from 0.6 to 4.3 ng/g and the ratio of tumor to plasma concentration from 0.5 to 1.8. In one patient who had CSF available for drug determination, the CSF to plasma ratio of total [3H]HHT was 0.3 at 45 minutes after drug administration and less than 0.2 ng/ml was unchanged HHT. For unchanged HHT, drug concentration in tumor ranged from undetectable (4 patients) to 1.8 ng/g. A major metabolite of HHT was detectable in the tumor specimens of all the patients. These results indicate that homoharringtonine can penetrate into brain tumors; in 3 patients with brain tumors, the ratios of HHT concentration in the tumor to that in the concurrent plasma were greater than one.

KW - central nervous system

KW - homoharringtonine

KW - penetration

UR - http://www.scopus.com/inward/record.url?scp=0023253529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023253529&partnerID=8YFLogxK

U2 - 10.1007/BF00162769

DO - 10.1007/BF00162769

M3 - Article

VL - 5

SP - 77

EP - 81

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -